From splitting GLUT1 deficiency syndromes to overlapping phenotypes.

Archive ouverte

Hully, Marie | Vuillaumier-Barrot, Sandrine | Le Bizec, Christiane | Boddaert, Nathalie | Kaminska, Anna | Lascelles, Karine | de Lonlay, Pascale | Cances, Claude | Des Portes, Vincent | Roubertie, Agathe | Doummar, Diane | Lebihannic, Anne | Degos, Bertrand | de Saint Martin, Anne | Flori, Elisabeth | Pedespan, Jean Michel | Goldenberg, Alice | Vanhulle, Catherine | Bekri, Soumeya | Roubergue, Anne | Héron, Bénédicte | Cournelle, Marie-Anne | Kuster, Alice | Chenouard, Alexis | Loiseau, Marie-Noelle | Valayannopoulos, Vassili | Chemaly, Nicole | Gitiaux, Cyril | Séta, Nathalie | Bahi-Buisson, Nadia

Edité par CCSD ; Elsevier -

International audience. Introduction Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare genetic disorder due to mutations or deletions in SLC2A1, resulting in impaired glucose uptake through the blood brain barrier. The classic phenotype includes pharmacoresistant epilepsy, intellectual deficiency, microcephaly and complex movement disorders, with hypoglycorrhachia, but milder phenotypes have been described (carbohydrate-responsive phenotype, dystonia and ataxia without epilepsy, paroxysmal exertion-induced dystonia). The aim of our study was to provide a comprehensive overview of GLUT1DS in a French cohort. Methods 265 patients were referred to the French national laboratory for molecular screening between July 2006 and January 2012. Mutations in SLC2A1 were detected in 58 patients, with detailed clinical data available in 24, including clinical features with a focus on their epileptic pattern and electroencephalographic findings, biochemical findings and neuroimaging findings. Results 53 point mutations and 5 deletions in SLC2A1 were identified. Most patients (87.5%) exhibited classic phenotype with intellectual deficiency (41.7%), epilepsy (75%) or movement disorder (29%) as initial symptoms at a medium age of 7.5 months, but diagnostic was delayed in most cases (median age at diagnostic 8 years 5 months). Sensitivity to fasting or exertion in combination with those 3 main symptoms were the main differences between mutated and negative patients (p < 0.001). Patients with myoclonic seizures (52%) evolved with more severe intellectual deficiency and movement disorders compared with those with Early Onset Absence Epilepsy (38%). Three patients evolved from a classic phenotype during early childhood to a movement disorder predominant phenotype at a late childhood/adulthood. Conclusions Our data confirm that the classic phenotype is the most frequent in GLUT1DS. Myoclonic seizures are a distinctive feature of severe forms. However a great variability among patients and overlapping through life from milder classic phenotype to paroxysmal-prominent- movement-disorder phenotype are possible, thus making it difficult to identify definite genotype–phenotype correlations.

Consulter en ligne

Suggestions

Du même auteur

KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP

Archive ouverte | Kuchenbuch, Mathieu | CCSD

International audience. Epilepsy of infancy with migrating focal seizures was first described in 1995. Fifteen years later, KCNT1 gene mutations were identified as the major disease-causing gene of this disease. Cur...

Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute management

Archive ouverte | Wicker, Camille | CCSD

International audience

LIS1-Related Isolated Lissencephaly. LIS1-Related Isolated Lissencephaly: Spectrum of Mutations and Relationships With Malformation Severity

Archive ouverte | Saillour, Yoann | CCSD

International audience. Objective: With the largest data set of patients with LIS1-related lissencephaly, the major cause of posteriorly predominant lissencephaly related to either LIS1 mutation or intragenic deleti...

Chargement des enrichissements...